WPI 1118 (Mirtazapine 30 mg)
Pill with imprint WPI 1118 is Yellow, Elliptical / Oval and has been identified as Mirtazapine 30 mg. It is supplied by Watson Pharmaceuticals.
Mirtazapine is used in the treatment of depression; major depressive disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 30 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 1118
Mirtazapine
- Imprint:
- WPI 1118
- Strength:
- 30 mg
- Color:
- Yellow
- Size:
- 13.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Tetracyclic antidepressants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-1118
- Inactive Ingredients:
-
- lactose anhydrous
- silicon dioxide
- magnesium stearate
- microcrystalline cellulose
- hypromellose 2910 (3 mPa.s)
- hypromellose 2910 (6 mPa.s)
- polyethylene glycol 400
- polysorbate 80
- titanium dioxide
- ferric oxide yellow
Note: Inactive ingredients may vary.
More about mirtazapine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 1376 Reviews
- Drug class: tetracyclic antidepressants
- FDA Alerts (4)
Consumer resources
- Mirtazapine
- Mirtazapine Orally Disintegrating Tablets
- Mirtazapine Tablets
- Mirtazapine (Advanced Reading)
Other brands: Remeron, Remeron SolTab
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
